Franklin Resources
EIGR

Franklin Resources’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History

Franklin Resources’s Portfolio EIGR Stock Details EIGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-525
Closed -$4.47M – 1645
2015
Q1 		$4.47M Buy
+525
New +$4.59M ﹤0.01% 1195

Other funds holding EIGR

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
TC
TFS Capital West Chester, Pennsylvania $255M AUM 32.31% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Franklin Resources's EIGR Position: Q2 2015 in Review

Franklin Resources sold out of Eiger BioPharmaceuticals, Inc. (EIGR) in Q2 2015, closing a stake of 525 shares — an estimated $4.47M sold.

Franklin Resources first reported a position in EIGR in Q1 2015 and held it in 1 quarter. The position peaked at $4.47M in Q1 2015. 44 funds tracked by Wall St. Rank hold EIGR as of Q2 2015.

  • Franklin Resources reported no remaining Eiger BioPharmaceuticals, Inc. position as of Q2 2015 after selling out during the quarter.
  • Franklin Resources sold 525 Eiger BioPharmaceuticals, Inc. shares in Q2 2015, an estimated $4.47M.
  • Franklin Resources first reported a position in Eiger BioPharmaceuticals, Inc. in Q1 2015 and held it in 1 quarter.
  • Franklin Resources's Eiger BioPharmaceuticals, Inc. position peaked at $4.47M in Q1 2015.
  • 44 funds tracked by Wall St. Rank held Eiger BioPharmaceuticals, Inc. as of Q2 2015.

Based on Franklin Resources's 13F filing for Q2 2015, filed 12 Aug 2015.